TY - JOUR T1 - Clinical Outcomes of Acute Myocardial Infarction Patients With a History of Malignant Tumor JF - In Vivo JO - In Vivo SP - 3589 LP - 3595 DO - 10.21873/invivo.12203 VL - 34 IS - 6 AU - MASASHI NOZAKA AU - HIROAKI YOKOYAMA AU - KAZUTAKA KITAYAMA AU - DAIKI NAGAWA AU - MISATO HAMADATE AU - NAOTAKE MIURA AU - YOSUKE KAWAMURA AU - MASAMICHI NAKATA AU - FUMIE NISHIZAKI AU - KENJI HANADA AU - TAKASHI YOKOTA AU - MASAHIRO YAMADA AU - HIROFUMI TOMITA Y1 - 2020/11/01 UR - http://iv.iiarjournals.org/content/34/6/3589.abstract N2 - Background: Little is known about the clinical outcomes of acute myocardial infarction (AMI) in patients with a history of malignant tumor (MT). Patients and Methods: We retrospectively studied 1,295 consecutive patients with AMI who underwent primary percutaneous coronary intervention within 24 hours of onset. The patients were divided into two groups: those with a history of MT (MT group, n=50) and those without (non-MT group, n=1,245). Results: The MT group was older, and had lower hemoglobin, total protein, and albumin levels. All-cause mortality and re-admission rates due to acute decompensated heart failure (ADHF) were significantly higher in the MT group. Multivariate analysis showed that a history of MT was an independent predictor for all-cause mortality and re-admission due to ADHF. Conclusion: The clinical outcomes of patients with AMI with a history of MT are poor, and a history of MT is an independent predictor for all-cause mortality and re-admission due to ADHF. These patients may need careful risk management for heart failure to avoid re-admissions due to ADHF. ER -